A differential diagnosis: clozapine-induced delirium or neuroleptic malignant syndrome?
___
1. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796.2. Meltzer HY. Treatment-resistant schizophrenia--the role of clozapine. Curr Med Res Opin 1997; 14:1-20.
3. Stanilla JK, de Leon J, Simpson GM. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases. J Clin Psychiatry 1997; 58:252-255.
4. Szymanski S, Jody D, Leipzig R, Masiar S, Lieberman J. Anticholinergic delirium caused by retreatment with clozapine. Am J Psychiatry 1991; 148:1752.
5. Benckhuijsen JA, Keet IP. Delirium on re-starting clozapine after a short break in treatment. Tijdschr Psychiatr 2007; 49:661-665. (Dutch)
6. Khanra S, Sethy RR, Munda SK, Khess CR. An Unusual Case of Delirium after Restarting Clozapine. Clin Psychopharmacol Neurosci 2016; 14:107-108.
7. Crilly J. The history of clozapine and its emergence in the US market: a review and analysis. Hist Psychiatry 2007; 18:39-60.
8. Baweja R, Sedky K, Lippmann S. Clozapine associated delirium. Eastern J Med 2010; 15: 71-72.
9. Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock’s Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. Eleventh ed. Philadelphia: Wolters Kluwer, 2014.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Fifth ed. (DSM-5). Washington DC: American Psychiatric Publishing, 2013.
11. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142:1137-1145.
12. Nielsen J, Bruhn AM. Atypical neuroleptic malignant syndrome caused by olanzapine. Acta Psychiatr Scand 2005; 112:238-240.
13. Spalding S, Alessi NE, Radwan K. Aripiprazole and atypical neuroleptic malignant syndrome. J Am Acad Child Adolesc Psychiatry 2004; 43:1457-1458.
14. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Psychopharmacol Bull 1988; 24:25-29.
15. Spivak M, Adams B, Crockford D. Atypical neuroleptic malignant syndrome with clozapine and subsequent haloperidol treatment. Can J Psychiatry 2003; 48:66.
- ISSN: 1018-8681
- Yayın Aralığı: Yılda 4 Sayı
- Başlangıç: 1984
- Yayıncı: Kare Yayıncılık
Associations between neurological soft signs, chronotype and sleep quality in schizophrenia
Esin EVREN KILIÇASLAN, Merve ATILGAN, Mustafa Cankut KURT, Murat BOYSAN, Mustafa GÜLEÇ
Murat EYÜBOĞLU, Damla EYÜPOĞLU
Zülal ÇELİK, Furkan Bahadır ALPTEKİN, Fatih Kaasim YAVUZ
The validity and reliability of DSM-5 separation anxiety disorder severity scale-adult form
Emine Özge ÇÖLDÜR, Fikret Poyraz ÇÖKMÜŞ, Didem SÜCÜLLÜOĞLU DİKİCİ, Ömer AYDEMİR
Investigation of the factors affecting cognitive test anxiety in university students
Hüseyin BURHAN, Mehmet Emrah KARADERE, Yasir Şafak, Tacettin KURU
Sexual dysfunction related with carbamazepine treatment: how much do we ask?
Sibel ÜSTÜN ÖZEK, Hazal Ceren AK, Serap ÜÇLER
CİHAT ÇELİK, İBRAHİM YİĞİT, Melike GUZEY YİĞİT, Gülsen ERDEN